PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 37 filers reported holding PROQR THRAPEUTICS N V in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $3,051,000 | -12.6% | 209,398 | 0.0% | 0.12% | +1.7% |
Q2 2015 | $3,491,000 | -23.8% | 209,398 | 0.0% | 0.12% | -21.6% |
Q1 2015 | $4,582,000 | -44.4% | 209,398 | -44.9% | 0.15% | -50.0% |
Q4 2014 | $8,235,000 | -9.6% | 380,000 | -28.3% | 0.30% | -10.8% |
Q3 2014 | $9,111,000 | – | 530,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $3,095,172 | 4.09% |
Privium Fund Management B.V. | 5,344,446 | $8,658,003 | 1.82% |
DAFNA Capital Management LLC | 940,582 | $1,523,743 | 0.42% |
Opaleye Management Inc. | 653,000 | $1,057,860 | 0.25% |
Ikarian Capital, LLC | 472,625 | $765,653 | 0.12% |
EcoR1 Capital, LLC | 2,980,016 | $4,827,626 | 0.12% |
Monaco Asset Management SAM | 237,517 | $384,778 | 0.11% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $243 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $5,873,257 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 189,328 | $306,711 | 0.01% |